Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL: 2070)

Saudi Pharmaceutical Industries and Medical Appliances Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	239.73	160.07	335.35	328.32	331.07	378.97
Short-Term Investments	100	115.5	45	-	128.99	-
Trading Asset Securities	0.48	0.46	0.42	567.67	614.56	27.83
Cash & Short-Term Investments	340.21	276.03	380.77	895.99	1,075	406.8
Cash Growth	44.05%	-27.51%	-57.50%	-16.62%	164.16%	52.19%
Accounts Receivable	1,284	924.09	758.9	971.8	980.52	930.95
Other Receivables	14.08	32.82	147.12	94.29	102.88	89.05
Receivables	1,298	956.91	906.03	1,066	1,083	1,020
Inventory	604.45	589.21	494.69	419.09	458.06	409.53
Prepaid Expenses	198.19	22.98	23.73	23.99	18.6	15.47
Other Current Assets	14.93	130.17	70.56	57.16	39.87	71.59
Total Current Assets	2,456	1,975	1,876	2,462	2,675	1,923
Property, Plant & Equipment	1,835	1,838	1,829	1,818	1,827	1,720
Long-Term Investments	61.24	58.19	46.53	63.3	80.41	890.45
Other Intangible Assets	85.43	59.77	50.33	69.54	81.29	97.87
Long-Term Accounts Receivable	-	57.56	-	-	-	-
Long-Term Deferred Tax Assets	30.01	28.6	23.48	18.93	17.5	23.72
Long-Term Deferred Charges	-	6.55	6.67	1.9	1.55	-
Total Assets	4,467	4,024	3,832	4,434	4,683	4,656
Accounts Payable	535.55	333.49	223.01	303.65	345.99	403.78
Accrued Expenses	136.2	208.83	87.14	125.91	90.59	69.45
Short-Term Debt	-	2.05	197.32	170.15	270.17	357.78
Current Portion of Long-Term Debt	1,037	523.41	479.64	682.6	416.36	176.48
Current Portion of Leases	3.83	7.21	6.15	7.26	3.32	3.69
Current Income Taxes Payable	53.43	48.45	33.14	28.84	39.66	37.12
Other Current Liabilities	233.13	281.19	322.44	321.34	405.59	451.67
Total Current Liabilities	1,999	1,405	1,349	1,640	1,572	1,500
Long-Term Debt	523.66	575.28	379.83	417.12	649.07	663.86
Long-Term Leases	8.68	11.3	18.81	17.69	12.71	7.97
Long-Term Unearned Revenue	81.34	81.93	77.95	70.23	67.69	58.14
Total Liabilities	2,841	2,356	2,139	2,441	2,612	2,541
Common Stock	1,200	1,200	1,200	1,200	1,200	1,200
Retained Earnings	329.56	356.68	366.29	649.68	664.49	320.96
Treasury Stock	-19.94	-8	-	-	-	-
Comprehensive Income & Other	-37.15	-42.03	-26.79	-11.91	51.04	422.58
Total Common Equity	1,472	1,507	1,540	1,838	1,916	1,944
Minority Interest	154.08	161.38	153.6	155.64	155.43	170.59
Shareholders' Equity	1,627	1,668	1,693	1,993	2,071	2,114
Total Liabilities & Equity	4,467	4,024	3,832	4,434	4,683	4,656
Total Debt	1,573	1,119	1,082	1,295	1,352	1,210
Net Cash (Debt)	-1,233	-843.22	-700.97	-398.82	-277.01	-802.98
Net Cash Per Share	-10.30	-7.03	-5.84	-3.32	-2.31	-6.69
Filing Date Shares Outstanding	119.63	120	120	120	120	120
Total Common Shares Outstanding	119.63	120	120	120	120	120
Working Capital	456.53	570.66	526.94	822.58	1,103	423.41
Book Value Per Share	12.31	12.56	12.83	15.31	15.96	16.20
Tangible Book Value	1,387	1,447	1,489	1,768	1,834	1,846
Tangible Book Value Per Share	11.59	12.06	12.41	14.74	15.29	15.38
Land	-	120.93	122.04	122.05	122.27	122.05
Buildings	-	1,006	772.75	776.76	776.96	696.27
Machinery	-	1,156	1,106	1,107	1,104	994.67
Construction In Progress	568.5	534	753.81	686.46	672.49	708.23

Source: S&P Capital IQ. Standard template. Financial Sources.